Valneva

Valneva EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Valneva (VLA.PA) as of Oct 19, 2026 is -16.28. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -12.45 — a change of 30.76% (lower).

EV/OCF

-16.28

YoY

30.76%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Valneva is 2025 -16.28 . EV/OCF (Enterprise Value to Operating Cash Flow) of Valneva was 2024 -12.45 . It decreases by 30.76% lower compared to the previous year.

The Valneva EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
47.19 EUR
Jan 1, 2019
146.46 EUR
Jan 1, 2020
5.01 EUR
Jan 1, 2021
7.24 EUR
Jan 1, 2022
-2.66 EUR
Jan 1, 2023
-4.30 EUR
Jan 1, 2024
-12.45 EUR
Jan 1, 2025
-16.28 EUR
The Valneva EV/OCF history
YEAREV/OCFYoY
-16.28+30.76%
-12.45+189.62%
-4.30+61.81%
-2.66-136.69%
7.24+44.58%
5.01-96.58%
146.46+210.35%
47.19-26.79%
64.46-49.86%
128.55-468.31%
-34.90-37.40%
-55.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Valneva is -16.28 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Valneva changed from -12.45 to -16.28, representing a 30.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Valneva since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valneva

All Key Metrics — Valneva